Monophosphoryl Lipid A Production via Phase-Controlled Bacterial Culture

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current methods for producing monophosphoryl lipid A (MPLA) face challenges in achieving high purity and efficiency due to the structural similarity and coexistence of lipid A and MPLA in bacteria, leading to contamination and impurity issues.

Innovation Solution

A method involving the culture of a bacterium producing MPLA from the exponential phase to the stationary phase, followed by lipid extraction and isolation using chromatography techniques, specifically ion-exchange and reversed-phase chromatography, to separate and purify MPLA from lipid A.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If lipid A and MPLA are produced together in bacteria, then productivity is improved, but manufacturing precision deteriorates due to contamination between the two substances

Engineering Contradiction:

Improveproduction efficiencyVSAvoidpurity

Core Design Contradiction:

ProductivityVSManufacturing precision

Solution Approach 1:

The patent divides the production process into distinct temporal phases: first producing lipid A during exponential growth, then producing MPLA during stationary phase. This temporal segmentation allows both substances to be produced in the same system without cross-contamination, as each substance dominates at different time points.

Inventive Principle:

Principle #1Segmentation

Solution Approach 2:

The patent performs preliminary lipid extraction during the exponential phase to obtain lipid A before MPLA production begins. By removing lipid A beforehand and controlling the culture to enter stationary phase, the system ensures that subsequent lipid extraction yields primarily MPLA with minimal lipid A contamination.

Inventive Principle:

Principle #10Preliminary action

2Productivity

If lipid extraction is performed from bacteria containing both lipid A and MPLA, then productivity is improved, but measurement precision deteriorates due to difficulty in distinguishing and measuring the two substances

Engineering Contradiction:

ImproveyieldVSAvoiddetection accuracy

Core Design Contradiction:

ProductivityVSMeasurement precision

Solution Approach 1:

The patent employs periodic sampling and analysis during the culture process to monitor the transition from lipid A dominance to MPLA dominance. By performing measurements at specific time intervals and comparing results against established patterns, the system can accurately determine when to switch extraction protocols, maintaining both high yield and measurement precision.

Inventive Principle:

Principle #19Periodic action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables the production of MPLA with high purity and efficiency, effectively distinguishing and isolating MPLA from lipid A, thereby overcoming contamination issues and achieving desired immunological properties without side effects.

Implementation Method 1

isolating MPLA from the obtained lipid

Methodology Applied

Scientific EffectIon exchange: Ion Exchange

Implementation Method 2

isolation using chromatography techniques, specifically ion-exchange and reversed-phase chromatography

Methodology Applied

Scientific EffectChromatography: Chromatography

Data Source

PatentUS12173342B2Method for producing monophosphoryl lipid A

Publication Date: 2024.12.24 EUBIOLOGICS CO LTD

AI summary

Provided is a method of producing monophosphoryl lipid A (MPLA). According to the method, MPLA may be produced with high purity and high purity by using a bacterium producing MPLA.